Clinical Trial Update: HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer [EARLY_Phase 1]

View source ↗

Summary

An early-phase (Phase 1) clinical trial evaluating a HER2-directed dendritic cell vaccine used with neoadjuvant therapy for HER2-positive breast cancer; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HER2-directed dendritic cell vaccine

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Breast Cancer, Breast Cancer Female | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING